Secretory Carcinoma of the Thyroid in a 49-Year-Old Man Treated with Larotrectinib: Protracted Clinical Course of Disease Despite the High-Grade Histologic Features
Author:
Funder
National Cancer Institute
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Otorhinolaryngology,Pathology and Forensic Medicine
Link
https://link.springer.com/content/pdf/10.1007/s12105-021-01386-6.pdf
Reference32 articles.
1. Chan JK, Albores-Saavedra J, Battifora H, Carcangiu ML, Rosai J. Sclerosing mucoepidermoid thyroid carcinoma with eosinophilia. A distinctive low-grade malignancy arising from the metaplastic follicles of Hashimoto’s thyroiditis. Am J Surg Pathol. 1991;15(5):438–48.
2. Rhatigan RM, Roque JL, Bucher RL. Mucoepidermoid carcinoma of the thyroid gland. Cancer. 1977;39(1):210–4.
3. Levy GH, Marti JL, Cai G, Kayne RD, Udelsman R, Hammers LW, et al. Pleomorphic adenoma arising in an incidental midline isthmic thyroid nodule: a case report and review of the literature. Hum Pathol. 2012;43(1):134–7.
4. Reynolds S, Shaheen M, Olson G, Barry M, Wu J, Bocklage T. A case of primary mammary analog secretory carcinoma (MASC) of the thyroid masquerading as papillary thyroid carcinoma: potentially more than a one off. Head Neck Pathol. 2016;10(3):405–13.
5. Dogan S, Wang L, Ptashkin RN, Dawson RR, Shah JP, Sherman EJ, et al. Mammary analog secretory carcinoma of the thyroid gland: A primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusion. Mod Pathol. 2016;29(9):985–95.
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Larotrectinib efficacy for liver metastases in papillary thyroid carcinoma patient harboring SQSTM1–NTRK1 fusion;Surgical Case Reports;2024-07-17
2. Update on Molecular Diagnostics in Thyroid Pathology: A Review;Genes;2023-06-22
3. Histological Classification of Thyroid Tumors by the New Fifth Edition of the WHO Classification;Thyroid FNA Cytology;2023
4. NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series;Journal of Personalized Medicine;2022-11-02
5. Update from the 2022 World Health Organization Classification of Thyroid Tumors: A Standardized Diagnostic Approach;Endocrinology and Metabolism;2022-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3